In the Low Dose Colchicine after Myocardial Infarction (LoDoCo-MI) study [171], which included 237 participants with an acute MI, 0.5 mg colchicine daily for 30 days was not associated with their primary endpoint of the proportion of patients with a residual CRP level < 2 mg/L at 30 days. This evidence concerns the gene CRP and myocardial infarction.